In a controversial ruling, the Scottish company ReNeuron has received authorization to conduct a clinical trial in which patients will be treated for corneal blindness with stem cells harvested from aborted human fetuses.
Scientists in Egypt demonstrate the ability of bone marrow stem cells to treat chronic cardiac disease that is associated with diabetes.
Researchers in Brazil have demonstrated improvement in muscular dystrophy patients following treatment with adult stem cells derived from umbilical cord blood.
Research in the United Kingdom with human-animal hybrid experimentation has ground to a halt due to lack of funding.
Pluristem Therapeutics has announced filing of applications with both the U.S. and European regulatory agencies to initiate clinical trials in the treatment of critical limb ischemia with adult stem cells.
Researchers at Stanford University have identified and isolated a population of highly potent adult stem cells from adult human testes.
